| Tuesday
7:30 AM - 9:30 AM | TU-AB-BRC-0 : Biomarkers of Response to Radiation and Immune Modulating Therapies for Advanced Cancer Management
D. Mankoff*, M. Farwell*, R. Li*, A. Wu*, K. Schalper*, S. Bowen*, |
| | 7:30 AM
TU-AB-BRC-1 | Introduction to the Biomarker Landscape
D. Mankoff* |
|
| | 7:35 AM
TU-AB-BRC-2 | Evolving Paradigm for Assessing Response to Immunomodulatory Therapies
M. Farwell* |
|
| | 7:55 AM
TU-AB-BRC-3 | Radiomics of Radiation and Immune Response Patterns
R. Li* |
|
| | 8:15 AM
TU-AB-BRC-4 | Clinical and Preclinical Imaging of the Immune System
A. Wu* |
|
| | 8:35 AM
TU-AB-BRC-5 | Role of Molecular Diagnostics and Advanced Tumor Tissue Analysis To Guide Optimal Anti-Cancer Treatment
K. Schalper* |
|
| | 8:55 AM
TU-AB-BRC-6 | Combining Imaging & Circulating Biomarkers of Response To Personalize Chemo-Immunotherapy and Radiation Therapy
S. Bowen* |
|
| | 9:15 AM
TU-AB-BRC-7 | Panel Discussion
|
|
